Efficacy and Safety of the DPP-IV Inhibitor PF-734200 Added to Metformin in Subjects with Type 2 Diabetes Mellitus

被引：0
|
作者：
Terra, Steven G.
Somayaji, Veena
Teeter, John G.
Dai, Haiqing
Nguyen, Tu T.
Ghazzi, Mahmoud
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A134 / A135
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: A randomized controlled trial
    Yang, Wenying
    Pan, Chang Yu
    Tou, Conrad
    Zhao, June
    Gause-Nilsson, Ingrid
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 94 (02) : 217 - 224
  • [22] Efficacy and safety of alogliptin added to metformin therapy in patients with type 2 diabetes
    Nauck, Michael
    Ellis, Graham
    Fleck, Penny
    Wilson, Craig
    Mekki, Qais
    DIABETES, 2008, 57 : A142 - A143
  • [23] Second line therapy: type 2 diabetic subjects failing on metformin GLP-1/DPP-IV inhibitors versus sulphonylurea/insulin: For GLP-1/DPP-IV inhibitors
    Kumar, Ajay
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2012, 28 : 21 - 25
  • [24] Safety of metformin in Type 2 diabetes mellitus
    Baigent, C
    Peto, R
    DIABETIC MEDICINE, 1999, 16 (02) : 89 - 90
  • [25] Implementation of GLP-1 based therapy of type 2 diabetes mellitus using DPP-IV inhibitors
    Holst, JJ
    DIPEPTIDYL AMINOPEPTIDASES IN HEALTH AND DISEASE, 2003, 524 : 263 - 279
  • [26] The DPP-IV inhibitor Linagliptin reported to be effective and safe in patients with type 2 diabetes independent of renal function
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2011, 13 (09): : 867 - 867
  • [27] Safety and Efficacy of Sitagliptin Added to the Combination of Sulfonylurea and Metformin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
    Round, Elizabeth
    Shentu, Yue
    Golm, Gregory T.
    O'Neill, Edward A.
    Gantz, Ira
    Engel, Samuel S.
    Kaufman, Keith D.
    Goldstein, Barry J.
    DIABETES, 2013, 62 : A299 - A299
  • [28] Incretins, incretinomimetics and DPP-IV inhibitors: glucose homeostasis and type 2 diabetes
    Virally, Marie
    Kevorkian, Jean-Philippe
    Guillausseau, Pierre-Jean
    SANG THROMBOSE VAISSEAUX, 2008, 20 (09): : 453 - 461
  • [29] Piperidinyl-2-phenethylamino inhibitors of DPP-IV for the treatment of Type 2 diabetes
    Benbow, John W.
    Andrews, Kim A.
    Aubrecht, Jiri
    Beebe, David
    Boyer, David
    Doran, Shawn
    Homiski, Michael
    Hui, Yu
    McPherson, Kirk
    Parker, Janice C.
    Treadway, Judith
    VanVolkenberg, Maria
    Zembrowski, William J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (08) : 2220 - 2223
  • [30] Progress in the Oral Treatment of Type 2 Diabetes: Update on DPP-IV Inhibitors
    Salvatore, Teresa
    Carbonara, Ornella
    Cozzolino, Domenico
    Torella, Roberto
    Sasso, Ferdinando C.
    CURRENT DIABETES REVIEWS, 2009, 5 (02) : 92 - 101
12345